Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Taisho researchers reveal cGMP-dependent phosphodiesterase (PDE V) inhibitors

May 31, 1996

Endothelin antagonists revealed by Fujisawa

May 31, 1996

Sanofi Winthrop research reveals elastase inhibitors

May 31, 1996

Nikken Chemicals reports antiallergic/antiinflammatory N-hydroxyureas

May 31, 1996

Hyaluronic acid and derivatives described by Hyal

May 31, 1996

Neurotrophic polypeptides disclosed by Children's Medical Center

May 31, 1996

Gedeon Richter discloses antiamnestic ethers

May 31, 1996

Pentynoic acid derivatives revealed by ABS and the University College Dublin

May 31, 1996

American Home Product reveals M1 receptor agonist

May 31, 1996

ACAT inhibitors from Warner-Lambert

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...